Home  >  News
  Medivir licenses rights to develop, manufacture & commercialise MIV-802 for Greater China to Ascletis,   August 19, 2017
  Mylan finalises $465 mn settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector with US DOJ,   August 19, 2017
  US FDA approves Pfizer's Besponsa to treat adults with relapsed/refractory B-cell precursor ALL,   August 19, 2017
  AstraZeneca & Merck announce Lynparza receives additional and broad approval from US FDA for ovarian cancer,   August 19, 2017
  Lion TCR receives two US FDA orphan drug designations for its T cell therapy products for HCC treatment,   August 18, 2017
  Exelixis seeks US FDA approval for Cabometyx for previously untreated advanced RCC,   August 18, 2017
  US FDA accepts Seattle Genetics' sBLA for Adcetris in CTCL and grants priority review status,   August 18, 2017
  Australian TGA approves Amicus' Galafold to treat Fabry disease \,   August 17, 2017
  Perrigo's generic Mycolog II cream receives US FDA approval,   August 17, 2017
  US FDA accepts Medivir's IND application for MIV-711,   August 17, 2017
  Shuttle Pharma, POLA Pharma enter pact to license US rights for doranidazole,   August 16, 2017
  Ionis Pharma to advance inotersen and IONIS-FB-L Rx drugs independently,   August 14, 2017
  US FDA warns of potential contamination in multiple brands of drugs, dietary supplements,   August 14, 2017
  Wellcome Trust Sanger Institute chooses NEBNext reagents of New England Biolabs for RNA sequencing,   August 14, 2017
  Gilead Sciences receives US FDA priority review status for FDC bictegravir,   August 12, 2017
  BioreclamationIVT buys biospecimen & research services provider Asterand Bioscience,   August 12, 2017
  US FDA issues draft guidance on Child-Resistant Packaging, paediatrics calls for immediate adoption,   August 12, 2017
  Lipocine resubmits NDA for LPCN 1021 to treat hypogonadism,   August 11, 2017
  InDex Pharma's cobitolimod receives US FDA orphan-drug status to treat ulcerative colitis in pediatric patients,   August 11, 2017
  Tissue Regenix buys CellRight Technologies to expand US presence in regenerative medicine,   August 11, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |